NDC 16729-216-01 - SERTRALINE HYDROCHLORIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 16729-216
- Requested NDC
- 16729-216-01
- Package NDCs from labels
- 16729-216-10, 16729-216-15, 16729-216-01, 16729-216-16, 16729-216-43
- Manufacturer
- PD-Rx Pharmaceuticals, Inc.
- Effective date
- 2026-05-21
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| SERTRALINE HYDROCHLORIDE - PD-Rx Pharmaceuticals, Inc. | PD-Rx Pharmaceuticals, Inc. | 2026-05-21 | HUMAN PRESCRIPTION DRUG LABEL |
| SERTRALINE HYDROCHLORIDE - Accord Healthcare, Inc. | Intas Pharmaceuticals Ltd | Accord Healthcare, Inc. | Intas Pharmaceuticals Ltd | 2025-12-17 | HUMAN PRESCRIPTION DRUG LABEL |
| SERTRALINE HYDROCHLORIDE - QPharma, Inc. | Northwind Health Company, LLC | QPharma, Inc. | Northwind Health Company, LLC | 2025-12-15 | HUMAN PRESCRIPTION DRUG LABEL |
| SERTRALINE HYDROCHLORIDE - Quality Care Products, LLC | Quality Care Products, LLC | 2024-12-18 | HUMAN PRESCRIPTION DRUG LABEL |
| SERTRALINE HYDROCHLORIDE - REMEDYREPACK INC. | REMEDYREPACK INC. | 2024-09-24 | HUMAN PRESCRIPTION DRUG LABEL |
| SERTRALINE HYDROCHLORIDE - Preferred Pharmaceuticals Inc. | Preferred Pharmaceuticals Inc. | 2024-08-07 | HUMAN PRESCRIPTION DRUG LABEL |
| SERTRALINE HYDROCHLORIDE - Bryant Ranch Prepack | Bryant Ranch Prepack | 2024-04-03 | HUMAN PRESCRIPTION DRUG LABEL |
| SERTRALINE HYDROCHLORIDE - RPK Pharmaceuticals, Inc. | RPK Pharmaceuticals, Inc. | 2023-08-18 | HUMAN PRESCRIPTION DRUG LABEL |
| SERTRALINE HYDROCHLORIDE - RPK Pharmaceuticals, Inc. | RPK Pharmaceuticals, Inc. | 2023-08-18 | HUMAN PRESCRIPTION DRUG LABEL |
| Sertraline Hydrochloride - Direct Rx | Direct Rx | 2023-01-12 | HUMAN PRESCRIPTION DRUG LABEL |
| SERTRALINE HYDROCHLORIDE - St. Mary's Medical Park Pharmacy | St. Mary's Medical Park Pharmacy | 2022-12-20 | HUMAN PRESCRIPTION DRUG LABEL |
| SERTRALINE HYDROCHLORIDE - A-S Medication Solutions | A-S Medication Solutions | 2022-04-13 | HUMAN PRESCRIPTION DRUG LABEL |
| SERTRALINE HYDROCHLORIDE - NuCare Pharmaceuticals,Inc. | NuCare Pharmaceuticals,Inc. | 2021-08-06 | HUMAN PRESCRIPTION DRUG LABEL |
| SERTRALINE HYDROCHLORIDE - Unit Dose Services | Unit Dose Services | 2021-05-20 | HUMAN PRESCRIPTION DRUG LABEL |
| Sertraline Hydrochloride Tablets USP | NuCare Pharmaceuticals, Inc. | 2021-02-12 | HUMAN PRESCRIPTION DRUG LABEL |
| SERTRALINE HYDROCHLORIDE - Denton Pharma, Inc. DBA Northwind Pharmaceuticals | Denton Pharma, Inc. DBA Northwind Pharmaceuticals | 2021-01-25 | HUMAN PRESCRIPTION DRUG LABEL |
| Sertraline Hydrochloride - Direct_Rx | Direct_Rx | 2021-01-07 | HUMAN PRESCRIPTION DRUG LABEL |
| SERTRALINE HYDROCHLORIDE - Proficient Rx LP | Proficient Rx LP | 2019-11-01 | HUMAN PRESCRIPTION DRUG LABEL |
| SERTRALINE HYDROCHLORIDE - Preferred Pharmaceuticals Inc. | Preferred Pharmaceuticals Inc. | 2019-04-26 | HUMAN PRESCRIPTION DRUG LABEL |
| SERTRALINE HYDROCHLORIDE - DIRECT RX | DIRECT RX | 2018-03-14 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 16729-216-01 | SERTRALINE HYDROCHLORIDE | 100 in 1 BOTTLE | TABLET, FILM COATED | 100 | 19 | |
| 16729-216-10 | SERTRALINE HYDROCHLORIDE | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 19 | |
| 16729-216-15 | SERTRALINE HYDROCHLORIDE | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | 19 | |
| 16729-216-16 | SERTRALINE HYDROCHLORIDE | 500 in 1 BOTTLE | TABLET, FILM COATED | 500 | 19 | |
| 16729-216-43 | SERTRALINE HYDROCHLORIDE | 100 in 1 BOX, UNIT-DOSE | TABLET, FILM COATED | 100 | 19 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 16729-216-15 | EA - Each | 16729-216 | 244cfc50-a442-4123-bebc-3fe1dd4c1f78 | 1 | 2017-03-06 |
| 16729-216-16 | EA - Each | 16729-216 | 03832b5b-daa3-4a2f-90be-0c1e4075fed3 | 1 | 2017-03-06 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dolce and Gabbana Everlast Foundation SPF 20 03W Light | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | 3b1e4480-8409-425e-b98d-eb4dcf2471e8 | 2025-08-04 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 06W Light | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | 3090422e-fc18-45b8-88f2-6a9b282a7205 | 2025-08-04 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 05N Light | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | f93aa5d2-90ab-4e11-874e-2ede4b25c4b6 | 2025-08-04 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 04C Light | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | f055cd51-7b1d-43df-8990-8f60ba1eb91c | 2025-08-04 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 07N Light | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | d4c76bc5-205b-45fd-8a02-4f4b17458503 | 2025-08-04 | Warnings | 15FIX9V2JP |
| Sertraline | SERTRALINE | A-S Medication Solutions | ad69cbfe-5b42-4714-a999-77d474e0849d | 2025-07-31 | Boxed warning, Warnings, Adverse reactions | 312940 UTI8907Y6X |
| Sertraline Hydrochloride | SERTRALINE HYDROCHLORIDE | Bryant Ranch Prepack | 50d0aef5-ecc7-49b0-964a-53f87058d22a | 2025-07-30 | Boxed warning, Warnings, Adverse reactions | 312941 UTI8907Y6X |
| Systane Ultra | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 0537c23a-15f7-be64-1231-a6c93468e9a8 | 2025-07-30 | Warnings | B697894SGQ |
| Systane | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 1d679d0f-cec2-a644-79cd-079607254bb9 | 2025-07-30 | Warnings | B697894SGQ |
| Systane Ultra Preservative Free | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 751fb85f-6683-4b0a-a650-324d4a74c5de | 2025-07-30 | Warnings | B697894SGQ |
| Neutrogena Mineral Invisible Daily Defense Face Sunscreen Broad Spectrum SPF 30 | TITANIUM DIOXIDE, ZINC OXIDE | Kenvue Brands LLC | 003123d2-9675-fdd2-e063-6294a90a0130 | 2025-07-28 | Warnings | 15FIX9V2JP |
| Neutrogena Mineral Ultra Sheer Face SPF 70 | TITANIUM DIOXIDE, ZINC OXIDE | Kenvue Brands LLC | 20e0badf-fe25-1d27-e063-6294a90a7cfe | 2025-07-28 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 01N Light | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | 2ccf4e45-4cec-417d-9f4c-28f376025f1d | 2025-07-25 | Warnings | 15FIX9V2JP |
| Sunscreen | TITANIUM DIOXIDE 6.8% | Baxter of California, LLC | 146030bc-2bf4-25ea-e063-6294a90a4613 | 2025-07-24 | Warnings | 15FIX9V2JP |
| La Defense Broad Spectrum SPF 30 Mineral Sunscreen | ZINC OXIDE, TITANIUM DIOXIDE | Luzern Laboratories, Inc | 3f00befa-415d-415d-89e1-6ba8770ba51e | 2025-07-21 | Warnings | 15FIX9V2JP |
| SERTRALINE | SERTRALINE | Aphena Pharma Solutions - Tennessee, LLC | 1548faf9-8625-f871-e063-6394a90a931f | 2025-07-21 | Boxed warning, Warnings, Adverse reactions | 312941 UTI8907Y6X |
| Schuessler Tissue Salts Calc Phos Bone Health 2 | CALCAREA PHOSPHORICA | Martin & Pleasance Pty Ltd | c277f1d8-2ee0-4111-adb6-38998f77dede | 2025-07-18 | Warnings | L11K75P92J |
| 3a2155d0-e79e-3e11-e063-6294a90a4aae | bf7cfd32-c8f8-4131-a6e5-5da1e6a1e126 | 2025-07-17 | Boxed warning, Warnings, Adverse reactions | bf7cfd32-c8f8-4131-a6e5-5da1e6a1e126 | ||
| Sertraline Hydrochloride | SERTRALINE HYDROCHLORIDE | Cipla USA Inc. | 3a3efb5f-b24a-438d-9253-371ff3b5417d | 2025-07-16 | Boxed warning, Warnings, Adverse reactions | UTI8907Y6X |
| Amarte ULTRA VEIL Daily | SUNSCREEN | Amarte USA LLC | 39e9ca98-d0e8-6b8f-e063-6394a90aa366 | 2025-07-15 | Warnings | 15FIX9V2JP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.